Looking again at the Lupski-ome
Back in 2009, as a fresh-faced young editor, I attended the second Cold Spring Harbor Personal Genomes meeting. Nowadays medical and individual genomes are… Read more »
Back in 2009, as a fresh-faced young editor, I attended the second Cold Spring Harbor Personal Genomes meeting. Nowadays medical and individual genomes are… Read more »
The biotechnology company Myriad Genetics holds US and European patents on the breast cancer risk genes BRCA1 and BRCA2 and sells a diagnostic test based on… Read more »
In 2013 Genome Medicine will launch a new thematic series focusing on Microbes in health and disease. This series will highlight advances in genome-scale and… Read more »
Whether you call it precision medicine or personalized medicine or any one of a number of other terms, one of the major goals in medical research is to be able… Read more »
Organising a conference feels a bit like the final stages of a PhD: spending months scouring the scientific literature, a gradual increase in stress levels,… Read more »
I’m very pleased that the program for Beyond the Genome 2011 is now available on the conference website. This BioMed Central conference, organised… Read more »
Many diseases, including some cancers, are associated with specific chromosomal trans-locations, and a technique reported in Genome Medicine provides a new way… Read more »
Anduril is an open-source computational framework for the combined analysis of molecular and clinical information developed by Sampsa Hautaniemi and colleagues… Read more »
According to research recently published in Genome Medicine, a complex of transcription factors which includes p53, NF-kappa-B and STAT3 is responsible for… Read more »
A molecular signature for biliary atresia classifies samples into inflammation or fibrosis stages at diagnosis and will be valuable for personalized clinical… Read more »